PGNY

Progyny Inc

36.58

Nov 12 • 3:59 PM ET +0.08 (0.22%)

36.58

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Healthcare Plans USA Mid NASD

Peers: HNGE CI OMDA HQY EVH UNH CVS TDOC IVF NIVF

| Held by: IJR AVUV IWM VTI VB SPSM IWO IJT VBK VXF

Scroll to Statements

Index	RUT
Market Cap	2.69B
Enterprise Value	2.52B
Income	91.02M
Sales	1.34B
Book/sh	5.54
Cash/sh	2.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	856
IPO	Oct 25, 2019

P/E	33.55
Forward P/E	22.92
PEG	0.55
P/S	2.01
P/B	6.60
P/C	13.70
P/FCF	15.00
EV/EBITDA	19.06
EV/Sales	1.88
Quick Ratio	1.93
Current Ratio	1.93
Debt/Eq	0.06
LT Debt/Eq	0.05
Option/Short	Yes / Yes

EPS (ttm)	1.09
EPS next Y	1.60
EPS next Q	0.36
EPS this Y	102.62%
EPS next Y	21.18%
EPS next 5Y	41.75%
EPS past 3/5Y	28.95% 6.78%
Sales past 3/5Y	17.87% 30.17%
EPS Y/Y TTM	74.23%
Sales Y/Y TTM	5.52%
EPS Q/Q	110.41%
Sales Q/Q	8.91%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	2.24% 0.14%

Insider Own	2.85%
Insider Trans	-24.22%
Inst Own	104.39%
Inst Trans	-3.58%
ROA	12.38%
ROE	18.69%
ROIC	20.89%
Gross Margin	24.87%
Oper. Margin	9.40%
Profit Margin	6.80%
SMA20	19.08%
SMA50	29.31%
SMA200	47.75%
Trades

Shs Outstand	74.72M
Shs Float	71.55M
Short Float	6.65%
Short Ratio	4.29
Short Interest	4.76M
52W High	36.52 0.16%
52W Low	16.10 127.20%
Volatility	3.17% 3.51%
ATR (14)	1.19
RSI (14)	83.36
Beta	0.94
Rel Volume	0.72
Avg Volume	1.11M
Volume	795,148

Perf Week	6.43%
Perf Month	31.39%
Perf Quarter	39.19%
Perf Half Y	59.95%
Perf YTD	42.45%
Perf Year	51.97%
Perf 3Y	21.21%
Perf 5Y	-39.76%
Perf 10Y	-
Recom	1.33
Target Price	37.25
Prev Close	36.50
Price	36.58
Change %	0.22%

Consensus

Strong Buy

Avg. Price Target

$37.25

Implied Upside

+1.8%

Analysts10incl. previous ratings

Rating Distribution6 Buy · 4 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Aug 20, 2026	Initiated	WWells Fargo	Overweight	$37	+1.1%
Jul 28, 2026	Downgrade	BBarclays	Overweight → Equal Weight	$34	-7.1%
May 19, 2026	Upgrade	CCanaccord Genuity	Hold → Buy	$30	-18.0%
Jan 20, 2026	Upgrade	CCitizens JMP	Mkt Perform → Mkt Outperform	$30	-18.0%
Jan 08, 2026	Upgrade	TTruist	Hold → Buy	$34	-7.1%
Dec 09, 2025	Initiated	BBarclays	Overweight	$29	-20.7%
Nov 12, 2025	Upgrade	KKeyBanc Capital Markets	Sector Weight → Overweight	$30	-18.0%
Jul 08, 2025	Upgrade	LLeerink Partners	Market Perform → Outperform	$28	-23.5%
Dec 02, 2024	Downgrade	JJP Morgan	Overweight → Neutral	$17	-53.5%
Nov 13, 2024	Downgrade	TTruist	Buy → Hold	$26 → $19	-48.1%
Sep 19, 2024	Downgrade	JJMP Securities	Mkt Outperform → Mkt Perform
Aug 07, 2024	Downgrade	LLeerink Partners	Outperform → Market Perform	$31 → $25	-31.7%
Aug 07, 2024	Downgrade	CCanaccord Genuity	Buy → Hold	$37 → $24	-34.4%
Aug 07, 2024	Downgrade	BBTIG Research	Buy → Neutral
Jul 16, 2024	Initiated	JJMP Securities	Mkt Outperform	$36	-1.6%
May 10, 2024	Downgrade	KKeyBanc Capital Markets	Overweight → Sector Weight
Feb 26, 2024	Initiated	LLeerink Partners	Outperform	$49	+34.0%
Jan 03, 2024	Initiated	BBarclays	Overweight	$48	+31.2%
Sep 27, 2023	Initiated	CCanaccord Genuity	Buy	$46	+25.8%
May 22, 2023	Initiated	BBTIG Research	Buy	$50	+36.7%

Nov-04-26 07:24PM	Progyny's Record Selling Season Outshines A Basis-Driven EPS Miss, But Margins Show Little Leverage (Earnings Whispers) +14.19%
04:14PM	Progyny: Q3 Earnings Snapshot (Associated Press)
04:01PM	Progyny, Inc. Announces Third Quarter 2026 Results (GlobeNewswire)
Oct-28-26 09:51AM	New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits (GlobeNewswire)
Oct-27-26 07:00PM	Progyny's Summer Engagement Dip Faces Its Test As Selling Season Momentum Builds (Earnings Whispers)
11:25AM	Loading…
Oct-26-26 11:25AM	New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model (GlobeNewswire)
Oct-21-26 10:43AM	Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report (GlobeNewswire)
Oct-15-26 09:34AM	Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting (GlobeNewswire)
Oct-07-26 08:28AM	Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics (GlobeNewswire) +6.33%
Sep-11-26 11:36AM	Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's What You Should Know (Quartz)
Sep-03-26 11:16AM	Progyny, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-24-26 07:00AM	Wells Fargo Conceives a High Rating for the Fertility-Benefits Biz (The Daily Upside)
Aug-07-26 10:51AM	Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference (GlobeNewswire) -6.98%
01:06AM	Progyny Inc (PGNY) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA Amid Strategic ... (GuruFocus.com)
Aug-06-26 04:37PM	Progyny: Q2 Earnings Snapshot (Associated Press)
04:01PM	Loading…
04:01PM	Progyny, Inc. Announces Second Quarter 2026 Results (GlobeNewswire)
Aug-05-26 09:27AM	Progyny Inc (PGNY) Q2 2026 Earnings Report Preview: What To Look For (GuruFocus.com)
Jul-23-26 03:30PM	Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report (GlobeNewswire)
May-28-26 09:04AM	New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System (GlobeNewswire)
May-26-26 08:00AM	Progyny, Inc. Announces Share Repurchase Program (GlobeNewswire)
May-19-26 09:34AM	StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls (The Fly)
May-11-26 10:57AM	Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference (GlobeNewswire)
May-08-26 10:58AM	Fertility Benefits Growth and Share Buybacks Keep Progyny (PGNY) Earnings in Focus (InvestorsHub) +23.80%
May-07-26 05:06PM	Progyny: Q1 Earnings Snapshot (Associated Press)
04:01PM	Progyny, Inc. Announces First Quarter 2026 Results (GlobeNewswire)
May-06-26 09:25AM	Progyny Inc (PGNY) Q1 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Apr-23-26 01:55PM	Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report (GlobeNewswire)
Apr-16-26 09:05AM	Progyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental Plan (GlobeNewswire)
Apr-01-26 09:23AM	Progyny Commemorates 10 Years of Redefining Women's Health and Family Building Care (GlobeNewswire)
Mar-06-26 09:02AM	Progyny, Inc. Executives to Participate in Upcoming Investor Conferences (GlobeNewswire)
12:35PM	Loading…
Feb-27-26 12:35PM	Why Progyny (PGNY) Shares Are Trading Lower Today (StockStory) -20.49%
04:30AM	Progyny Q4 Earnings Call Highlights (MarketBeat)
12:03AM	Progyny Inc (PGNY) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... (GuruFocus.com)
Feb-26-26 06:45PM	Progyny (PGNY) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:30PM	Compared to Estimates, Progyny (PGNY) Q4 Earnings: A Look at Key Metrics (Zacks)
05:20PM	Progyny: Q4 Earnings Snapshot (Associated Press Finance)
04:12PM	Progyny's (NASDAQ:PGNY) Q4 CY2025: Beats On Revenue (StockStory)
04:01PM	Progyny, Inc. Announces Fourth Quarter 2025 Results (GlobeNewswire)
Feb-25-26 09:15AM	Seeking Clues to Progyny (PGNY) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
07:28AM	What To Expect From Progyny Inc (PGNY) Q4 2025 Earnings (GuruFocus.com)
Feb-24-26 10:07PM	Progyny (PGNY) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-12-26 02:46PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report (GlobeNewswire)
Jan-22-26 07:20AM	Progyny price target raised to $35 from $30 at BTIG (TipRanks)
03:23AM	Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves (Insider Monkey)
Jan-20-26 03:10PM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Jan-14-26 11:35PM	3 Hyped Up Stocks That Concern Us (StockStory) -6.93%
Jan-12-26 10:07AM	Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny (Zacks) +5.30%
08:00AM	Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:15AM	Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? (Zacks)
09:04AM	3 Medical Service Industry Stocks Set to Tackle Workforce Challenges (Zacks)
Jan-08-26 11:36AM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Dec-31-25 11:04PM	2 Reasons PGNY is Risky and 1 Stock to Buy Instead (StockStory)
Dec-23-25 09:15AM	Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? (Zacks) -5.16%
Dec-22-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
Dec-16-25 11:32PM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Dec-15-25 12:00PM	Progyny (PGNY) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-08-25 11:31PM	1 Russell 2000 Stock with Impressive Fundamentals and 2 Facing Headwinds (StockStory)
Dec-07-25 11:39PM	2 Stocks Under $50 on Our Watchlist and 1 We Find Risky (StockStory)
Nov-25-25 09:15AM	Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-24-25 12:45PM	Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-20-25 09:23AM	New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action (GlobeNewswire)
Nov-18-25 09:15AM	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-17-25 10:37PM	A Look Back at Health Insurance Providers Stocks' Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack (StockStory) +9.25%
Nov-14-25 11:40AM	PGNY vs. HQY: Which Stock Is the Better Value Option? (Zacks)
Nov-13-25 12:33PM	Progyny, Inc. to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
12:37AM	5 Must-Read Analyst Questions From Progyny's Q3 Earnings Call (StockStory)
Nov-12-25 11:35PM	3 Inflated Stocks with Warning Signs (StockStory)
09:45AM	Carvana initiated, AT upgraded: Wall Street's top analyst calls (The Fly)
Nov-07-25 01:02PM	Why Progyny Stock Is Soaring Today (Motley Fool) +24.21%
09:21AM	PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum (StockStory)
12:08AM	Progyny Inc (PGNY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
Nov-06-25 05:20PM	Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:13PM	Progyny: Q3 Earnings Snapshot (Associated Press Finance)
04:08PM	Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars (StockStory)
04:01PM	Progyny, Inc. Announces Third Quarter 2025 Results (GlobeNewswire)
Nov-05-25 07:36AM	Earnings To Watch: Progyny Inc (PGNY) Reports Q3 2025 Result (GuruFocus.com)
Nov-04-25 10:09PM	Progyny (PGNY) Q3 Earnings: What To Expect (StockStory)
Oct-27-25 03:13AM	3 Small-Cap Stocks with Warning Signs (StockStory)
Oct-23-25 01:08PM	Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report (GlobeNewswire)
09:40AM	Are Investors Undervaluing Progyny (PGNY) Right Now? (Zacks)
Oct-22-25 04:55PM	Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks (Motley Fool)
09:28AM	Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause (GlobeNewswire)
Oct-07-25 09:40AM	Is Progyny (PGNY) Stock Undervalued Right Now? (Zacks)
09:30AM	Progyny CEO Named World Economic Forum Champion for Women's Health (GlobeNewswire)
Oct-02-25 12:04AM	3 Reasons to Avoid PGNY and 1 Stock to Buy Instead (StockStory)
Sep-26-25 08:05AM	A Healthcare Debate: Progyny vs. Hims & Hers (Motley Fool)
Sep-15-25 11:32PM	Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY) (StockStory)
Sep-05-25 02:36PM	Why Progyny (PGNY) Stock Is Trading Lower Today (StockStory)
Sep-01-25 12:20PM	Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock (Zacks)
09:15AM	CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-27-25 12:32PM	Progyny (PGNY) Stock Trades Up, Here Is Why (StockStory)
Aug-21-25 12:33AM	1 Russell 2000 Stock with Impressive Fundamentals and 2 We Ignore (StockStory)
Aug-18-25 02:40PM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Aug-14-25 01:35AM	5 Must-Read Analyst Questions From Progyny's Q2 Earnings Call (StockStory)
Aug-12-25 09:00AM	URA Advances Womens Health with First-of-its-Kind Support for Pregnancy and Menopause, Bridging Gaps in Care with Personalized Biometrics and Clinical Integrations (Business Wire)
03:07AM	PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance (StockStory)
Aug-08-25 03:38AM	Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ... (GuruFocus.com)
Aug-07-25 06:20PM	Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates (Zacks)
05:30PM	Progyny: Q2 Earnings Snapshot (Associated Press Finance)
04:48PM	Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic (StockStory)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 10 '26	Option Exercise	0.91	185,134	168,472	947,602	Nov 12 05:31 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 10 '26	Sale	35.84	236,630	8,481,919	710,972	Nov 12 05:31 PM
Schlanger David J	Executive Chairman	Nov 10 '26	Option Exercise	0.91	35,392	32,207	273,854	Nov 12 05:30 PM
Schlanger David J	Executive Chairman	Nov 10 '26	Sale	35.36	35,392	1,251,507	238,462	Nov 12 05:30 PM
Clapp Geoffrey	Officer	Nov 11 '26	Proposed Sale	36.41	774	28,181		Nov 12 07:01 AM
ANEVSKI 2026 SOUTH DAKOTA NGCG	Director	Nov 10 '26	Proposed Sale	35.95	50,139	1,802,497		Nov 10 04:30 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 09 '26	Option Exercise	0.91	126,204	114,846	923,776	Nov 09 09:57 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 05 '26	Option Exercise	0.91	3,400	3,094	809,511	Nov 09 09:57 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 09 '26	Sale	35.73	161,308	5,762,841	762,468	Nov 09 09:57 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 05 '26	Sale	35.13	11,939	419,412	797,572	Nov 09 09:57 PM
Schlanger David J	Executive Chairman	Nov 09 '26	Option Exercise	0.91	161,208	146,699	399,670	Nov 09 09:55 PM
Schlanger David J	Executive Chairman	Nov 05 '26	Option Exercise	0.91	3,400	3,094	241,862	Nov 09 09:55 PM
Schlanger David J	Executive Chairman	Nov 09 '26	Sale	35.73	161,208	5,759,365	238,462	Nov 09 09:55 PM
Schlanger David J	Executive Chairman	Nov 05 '26	Sale	35.22	3,400	119,751	238,462	Nov 09 09:55 PM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Nov 04 '26	Sale	30.00	2,139	64,170	70,314	Nov 06 04:06 PM
DAVID SCHLANGER	Director	Nov 05 '26	Proposed Sale	30.10	200,000	6,020,000		Nov 05 04:30 PM
ANEVSKI 2026 SOUTH DAKOTA NGCG	Director	Nov 05 '26	Proposed Sale	30.10	90,000	2,709,000		Nov 05 04:28 PM
PETER ANEVSKI	Director	Nov 05 '26	Proposed Sale	30.10	314,738	9,473,614		Nov 05 04:27 PM
Livingston Mark S.	Officer	Nov 04 '26	Proposed Sale	30.00	2,139	64,170		Nov 04 12:22 PM
Cummings Melissa B	Chief Operating Officer	Oct 14 '26	Sale	28.00	1,879	52,612	66,496	Oct 16 04:56 PM
Cummings Melissa B	Officer	Oct 14 '26	Proposed Sale	28.00	1,879	52,612		Oct 14 01:51 PM
Swartz Allison	EVP, GC	Sep 23 '26	Sale	26.10	3,903	101,868	75,816	Sep 28 04:30 PM
Swartz Allison	Officer	Sep 23 '26	Proposed Sale	26.10	3,903	101,868		Sep 23 11:36 AM
GORDON KEVIN K	Director	Sep 10 '26	Option Exercise	13.00	22,000	286,000	28,792	Sep 14 05:53 PM
GORDON KEVIN K	Director	Sep 10 '26	Sale	27.94	11,500	321,358	6,792	Sep 14 05:53 PM
GORDON KEVIN K	Director	Sep 10 '26	Proposed Sale	27.12	11,500	311,859		Sep 10 01:58 PM
Cummings Melissa B	Chief Operating Officer	Jul 14 '26	Sale	31.60	2,244	70,910	69,934	Jul 16 04:16 PM
Cummings Melissa B	Officer	Jul 14 '26	Proposed Sale	31.60	2,244	70,910		Jul 14 09:46 AM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Jun 04 '26	Sale	25.50	2,517	64,184	74,688	Jun 05 04:38 PM
Swartz Allison	EVP, GC	Jun 03 '26	Sale	25.02	1,199	29,999	83,316	Jun 05 04:38 PM
Swartz Allison	EVP, GC	Jun 04 '26	Sale	25.08	599	15,023	82,378	Jun 05 04:38 PM
Livingston Mark S.	Officer	Jun 04 '26	Proposed Sale	25.50	2,517	64,184		Jun 04 01:39 PM
Swartz Allison	Officer	Jun 04 '26	Proposed Sale	25.08	599	15,023		Jun 04 11:19 AM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Jun 02 '26	Sale	26.20	279	7,310	78,626	Jun 03 04:54 PM
Scott Cheryl	Director	Jun 01 '26	Option Exercise	13.00	14,667	190,671	34,439	Jun 03 04:53 PM
Scott Cheryl	Director	Jun 01 '26	Sale	26.39	7,439	196,278	19,772	Jun 03 04:53 PM
Clapp Geoffrey	Chief Product Officer	Jun 02 '26	Option Exercise	20.91	12,909	269,927	72,026	Jun 03 04:52 PM
Clapp Geoffrey	Chief Product Officer	Jun 02 '26	Sale	25.58	1,530	39,137	59,117	Jun 03 04:52 PM
Swartz Allison	Officer	Jun 03 '26	Proposed Sale	25.02	1,199	29,999		Jun 03 09:59 AM
Clapp Geoffrey	Officer	Jun 02 '26	Proposed Sale	25.58	1,530	39,137		Jun 02 03:03 PM
Livingston Mark S.	Officer	Jun 02 '26	Proposed Sale	26.20	279	7,310		Jun 02 12:22 PM
Swartz Allison	EVP, GC	May 28 '26	Sale	25.46	2,398	61,053	85,191	Jun 01 04:08 PM
Scott Cheryl	Director	Jun 01 '26	Proposed Sale	26.39	7,439	196,278		Jun 01 02:48 PM
GORDON KEVIN K	Director	May 27 '26	Sale	24.99	5,500	137,445	9,318	May 29 04:16 PM
Swartz Allison	Officer	May 28 '26	Proposed Sale	25.46	2,398	61,053		May 28 10:17 AM
GORDON KEVIN K	Director	May 27 '26	Proposed Sale	24.99	5,500	137,445		May 27 11:25 AM
Scott Cheryl	Director	May 22 '26	Proposed Sale	24.73	2,676	66,177		May 22 12:15 PM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	May 20 '26	Sale	25.50	8,275	211,012	79,063	May 21 04:23 PM
Cummings Melissa B	Chief Operating Officer	May 19 '26	Sale	25.00	9,578	239,450	73,371	May 21 04:22 PM
Livingston Mark S.	Officer	May 20 '26	Proposed Sale	25.50	8,275	211,012		May 20 03:07 PM
Cummings Melissa B	Officer	May 19 '26	Proposed Sale	25.00	9,578	239,450		May 19 11:52 AM
Swartz Allison	EVP, GC	Mar 04 '26	Sale	17.54	599	10,506	88,941	Mar 06 04:36 PM
Swartz Allison	EVP, GC	Mar 03 '26	Sale	17.40	4,657	81,030	89,879	Mar 04 05:31 PM
Swartz Allison	EVP, GC	Mar 02 '26	Sale	17.27	2,199	37,977	97,378	Mar 04 05:31 PM
Swartz Allison	Officer	Mar 04 '26	Proposed Sale	17.54	599	10,506		Mar 04 12:00 PM
Swartz Allison	Officer	Mar 03 '26	Proposed Sale	17.40	4,657	81,030		Mar 03 02:59 PM
Swartz Allison	Officer	Mar 02 '26	Proposed Sale	17.27	2,199	37,977		Mar 02 02:54 PM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Dec 11 '25	Sale	25.50	459	11,704	46,983	Dec 15 04:12 PM
Livingston Mark S.	Officer	Dec 11 '25	Proposed Sale	25.50	459	11,704		Dec 11 02:55 PM
Swartz Allison	EVP, GC	Dec 04 '25	Sale	24.59	530	13,033	72,719	Dec 08 04:23 PM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Dec 02 '25	Sale	25.50	213	5,432	47,921	Dec 04 04:17 PM
Swartz Allison	Officer	Dec 04 '25	Proposed Sale	24.59	530	13,033		Dec 04 09:41 AM
Swartz Allison	EVP, GC	Nov 28 '25	Sale	26.87	2,398	64,434	73,657	Dec 02 04:15 PM
Livingston Mark S.	Officer	Dec 02 '25	Proposed Sale	25.50	213	5,432		Dec 02 10:24 AM
Swartz Allison	Officer	Nov 28 '25	Proposed Sale	26.87	2,398	64,434		Nov 28 09:39 AM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Nov 17 '25	Sale	25.50	21,303	543,226	48,358	Nov 19 05:03 PM
Payson Norman	Director	Nov 14 '25	Option Exercise	1.45	36,224	52,525	56,954	Nov 18 04:48 PM
Livingston Mark S.	Officer	Nov 17 '25	Proposed Sale	25.50	21,303	543,226		Nov 17 12:31 PM

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Executive ChairmanMr. David J. Schlanger J.D.

CEO & DirectorMr. Peter Anevski CPA

Chief Financial OfficerMr. Mark S. Livingston CPA

Chief Operating OfficerMs. Melissa B. Cummings

Executive VPMs. Allison Swartz

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

PGNY

Progyny Inc

Upgrade your Finviz experience

All the Features.
Half the Price.